1MZC image
Deposition Date 2002-10-07
Release Date 2003-07-08
Last Version Date 2024-02-14
Entry Detail
PDB ID:
1MZC
Keywords:
Title:
Co-Crystal Structure Of Human Farnesyltransferase With Farnesyldiphosphate and Inhibitor Compound 33a
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.00 Å
R-Value Free:
0.20
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
P 61
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Protein Farnesyltransferase alpha Subunit
Gene (Uniprot):FNTA
Chain IDs:A
Chain Length:382
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Protein Farnesyltransferase beta Subunit
Gene (Uniprot):FNTB
Chain IDs:B
Chain Length:437
Number of Molecules:1
Biological Source:Homo sapiens
Peptide-like Molecules
PRD_900003
Primary Citation
Dual Protein Farnesyltransferase-Geranylgeranyltransferase-I Inhibitors as Potential Cancer Chemotherapeutic Agents.
J.Med.Chem. 46 2973 2984 (2003)
PMID: 12825937 DOI: 10.1021/jm020587n

Abstact

A series of novel diaryl ether lactams have been identified as very potent dual inhibitors of protein farnesyltransferase (FTase) and protein geranylgeranyltransferase I (GGTase-I), enzymes involved in the prenylation of Ras. The structure of the complex formed between one of these compounds and FTase has been determined by X-ray crystallography. These compounds are the first reported to inhibit the prenylation of the important oncogene Ki-Ras4B in vivo. Unfortunately, doses sufficient to achieve this endpoint were rapidly lethal.

Legend

Protein

Chemical

Disease

Primary Citation of related structures